Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication

Objective In large cohort studies comorbidities are usually self-reported by the patients. This way to collect health information only represents conditions known, memorized and openly reported by the patients. Several studies addressed the relationship between self-reported comorbidities and medical records or pharmacy data, but none of them provided a structured, documented method of evaluation. We thus developed a detailed procedure to compare self-reported comorbidities with information on comorbidities derived from medication inspection. This was applied to the data of the German COPD cohort COSYCONET. Methods Approach I was based solely on ICD10-Codes for the diseases and the indications of medications. To overcome the limitations due to potential non-specificity of medications, Approach II was developed using more detailed information, such as ATC-Codes specific for one disease. The relationship between reported comorbidities and medication was expressed by a four-level concordance score. Results Approaches I and II demonstrated that the patterns of concordance scores markedly differed between comorbidities in the COSYCONET data. On average, Approach I resulted in more than 50% concordance of all reported diseases to at least one medication. The more specific Approach II showed larger differences in the matching with medications, due to large differences in the disease-specificity of drugs. The highest concordance was achieved for diabetes and three combined cardiovascular disorders, while it was substantial for dyslipidemia and hyperuricemia, and low for asthma. Conclusion Both approaches represent feasible strategies to confirm self-reported diagnoses via medication. Approach I covers a broad spectrum of diseases and medications but is limited regarding disease-specificity. Approach II uses the information from medications specific for a single disease and therefore can reach higher concordance scores. The strategies described in a detailed and reproducible manner are generally applicable in large studies and might be useful to extract as much information as possible from the available data.

[1]  R. Holle,et al.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.

[2]  R. Holle,et al.  Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study. , 2016, Respiratory medicine.

[3]  J. Thumboo,et al.  Comparison of the Charlson Comorbidity Index derived from self-report and medical record review in Asian patients with rheumatic diseases , 2015, Rheumatology International.

[4]  A. Scheen,et al.  Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control. , 2015, Diabetes & metabolism.

[5]  C. Paúl,et al.  Determinants of frailty: the added value of assessing medication , 2015, Front. Aging Neurosci..

[6]  Changwei Li,et al.  Validity of self-reported diabetes among middle-aged and older Chinese adults: the China Health and Retirement Longitudinal Study , 2015, BMJ Open.

[7]  B. Cosío,et al.  Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? , 2014, International journal of chronic obstructive pulmonary disease.

[8]  K. Farrington,et al.  A self-report comorbidity questionnaire for haemodialysis patients , 2014, BMC Nephrology.

[9]  Javier A. Neyra,et al.  Hemodialysis catheter insertion: is increased PO2 a sign of arterial cannulation? A case report , 2014, BMC Nephrology.

[10]  A. Menezes,et al.  Comorbidities and Health Status in Individuals With and Without COPD in Five Latin American Cities: The PLATINO Study ☆ , 2013 .

[11]  J. Jardim,et al.  Comorbilidades y estado de salud en individuos con y sin EPOC en 5 ciudades de América Latina: Estudio PLATINO , 2013 .

[12]  L. Edwards,et al.  Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. , 2013, Respiratory medicine.

[13]  C. Teljeur,et al.  Multimorbidity in a cohort of patients with type 2 diabetes , 2013, The European journal of general practice.

[14]  Bruce Leff,et al.  The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008 , 2012, BMC Pulmonary Medicine.

[15]  A. Lindberg,et al.  Up-to-date on mortality in COPD - report from the OLIN COPD study , 2012, BMC Pulmonary Medicine.

[16]  R. Pistelli,et al.  Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease , 2011, Current opinion in pulmonary medicine.

[17]  C. Dowrick,et al.  The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort , 2012, Social Psychiatry and Psychiatric Epidemiology.

[18]  R. Marrie,et al.  Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis , 2010, Neuroepidemiology.

[19]  C. Vogelmeier,et al.  Einfluss systemischer Manifestationenund Komorbiditäten auf den klinischen Zustand und den Verlaufbei COPD , 2010 .

[20]  C. Vogelmeier,et al.  [Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET]. , 2010, Deutsche medizinische Wochenschrift.

[21]  M. Marzilli Pleiotropic Effects of Statins , 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[22]  M. Casas,et al.  A method to estimate expected day-surgery activity in hospitals of the Spanish National Health System , 2008, BMC Health Services Research.

[23]  Manfred Stommel,et al.  "Concordance between comorbidity data from patient self-report interviews and medical record documentation" , 2008, BMC health services research.

[24]  Kenneth D. Mandl,et al.  Research Paper: The Value of Patient Self-report for Disease Surveillance , 2007, J. Am. Medical Informatics Assoc..

[25]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[26]  Carol M. Mangione,et al.  What is the Concordance Between the Medical Record and Patient Self-Report as Data Sources for Ambulatory Care? , 2006, Medical care.

[27]  Robert A. Israel,et al.  International Classification of Diseases (ICD) , 2005 .

[28]  U. Laufs,et al.  Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[29]  Douglas W Mahoney,et al.  Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. , 2004, Journal of clinical epidemiology.

[30]  R. J. Brown,et al.  Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  L. Fried,et al.  Agreement Between Self‐Report of Disease Diagnoses and Medical Record Validation in Disabled Older Women: Factors That Modify Agreement , 2004, Journal of the American Geriatrics Society.

[32]  Paul A. Fishman,et al.  Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model , 2003, Medical care.

[33]  J. Farmer Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[34]  B. Penninx,et al.  Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. , 1996, Journal of clinical epidemiology.